vimarsana.com
Home
Live Updates
Long-term Clopidogrel Has Advantages After Coronary Stenting
Long-term Clopidogrel Has Advantages After Coronary Stenting
Long-term Clopidogrel Has Advantages After Coronary Stenting
Clopidogrel after PCI was noninferior to aspirin for net adverse clinical events but superior in reducing secondary endpoints of stroke and MI, in 5-year STOPDAPT-2 results.
Related Keywords
Paris ,
France General ,
France ,
Hirakata ,
Osaka ,
Japan ,
Antibes ,
Provence Alpes Côd Azur ,
Japanese ,
Hirotoshi Watanabe ,
Anne Bellemain Appaix ,
Journal Of The American College Cardiology ,
Cardiology Department ,
Sorbonne University ,
Department Of Cardiology ,
Optimal Duration ,
Dual Antiplatelet Therapy ,
Antibes Hospital ,
Hirakata Kohsai Hospital ,
American College ,
Acute Coronary Syndrome Acs ,
Aspirin ,
Acetylsalicylic Acid ,
Thromboembolism ,
Stroke Cerebrovascular Accident Cva ,
Neuroendocrine Tumor Tumour ,
Pet ,
Jets ,
Euroendocrine Tumor Net ,
Euroendocrine Tumors Nets ,
Euroendocrine Tumour Net ,
Euroendocrine Tumours Nets ,
Colorectal Cancer ,